Loading clinical trials...
Loading clinical trials...
An Observational Study to Characterize Patient Global Impression Questions for Activity-induced Symptoms in Patients With Pulmonary Arterial Hypertension (PAH)
Conditions
Interventions
Treprostinil
Non-Treprostinil PAH Medications
Locations
10
United States
The University of Alabama at Birmingham
Birmingham, Alabama, United States
Cedars-Sinai Medical Center
Beverly Hills, California, United States
Santa Barbara Pulmonary Associates
Santa Barbara, California, United States
St. Francis Sleep, Allergy & Lung Institute
Clearwater, Florida, United States
Pulmonary & Critical Care of Atlanta
Atlanta, Georgia, United States
Kentuckiana Pulmonary Associates
Louisville, Kentucky, United States
Start Date
April 1, 2019
Primary Completion Date
September 19, 2019
Completion Date
September 19, 2019
Last Updated
March 16, 2021
NCT07218029
NCT07120789
NCT06649110
NCT04778046
NCT06481852
NCT06477640
Lead Sponsor
United Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions